LDL oxidation by activated monocytes: Characterization of the oxidized LDL and requirement for transition metal ions

Journal of Lipid Research

Volumn 39, Issue 11, 1998, Pages 2201-2208

  Xing, Xiaoyan ^a,b   Baffic, Joanne ^a   Sparrow, Carl P ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b IMMUNOMEDICS INC   (United States)

Author keywords

Atherosclerosis; Cholesterol; Iron; Scavneger receptor; Superoxide; Zymosan

Indexed keywords

COPPER SULFATE; EDETIC ACID; IRON; LIPOXYGENASE; LYSOPHOSPHATIDYLCHOLINE; METAL ION; MYELOPEROXIDASE; OXIDIZED LOW DENSITY LIPOPROTEIN; PENTETIC ACID; PHORBOL ESTER; SCAVENGER RECEPTOR; SUPEROXIDE; ZYMOSAN;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHELATION; CONTAMINATION; ELECTROPHORETIC MOBILITY; ENZYME ACTIVITY; FLUORESCENCE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LIPID COMPOSITION; LIPID OXIDATION; LIPID PEROXIDATION; LIPOPROTEIN METABOLISM; MONOCYTE; NORMAL HUMAN; OPSONIZATION; PRIORITY JOURNAL; RADIOLYSIS; SPECTROPHOTOMETRY;

CELLS, CULTURED; HUMANS; IRON; LIPOPROTEINS, LDL; LYMPHOCYTE ACTIVATION; METALS; MONOCYTES; NITRIC OXIDE; SUPEROXIDES; ZYMOSAN;

EID: 0031754371     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Steinberg, D., S. Parthasarathy, T. E. Carew, J. C. Khoo, and J. L. Witztum. 1989. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N. Eng. J. Mol. 320: 915-924.
2. Heinecke, J. W. 1997. Mechanisms of oxidative damage of LDL in human atherosclerosis. Curr. Opin. Lipidol. 8: 268-274.
3. Yla-Herttuala, S., W. Palinski, M. E. Rosenfeld, S. Parthasarathy, T. E. Carew, S. Butler, J. L. Witztum, and D. Steinberg. 1989. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84: 1086-1095.
4. Carew, T. E., D. C. Schwenke, and D. Steinberg. 1987. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc. Natl. Acad. Sci. USA. 84: 7725-7729.
5. Björkhem, I., A. Henriksson-Freyschuss, O. Breuer, U. Diczfalusy, L. Berglund, and P. Henriksson. 1991. The antioxidant butylated hydroxytoluene protects against atherosclerosis. Arterioscler. Thromb. 11: 15-22.
6. Sparrow, C. P., T. W. Doebber, J. Olszewski, M. S. Wu, J. Ventre, K. A. Stevens, and Y-S. Chao. 1992. Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N′-diphenylphenylenediamine. J. Clin. Invest. 89: 1885-1891.
7. Wu, Y., C. Hong, S. Lin, P. Wu and M. Shiao. 1998. Increase of vitamin E content in LDL and reduction of atherosclerosis in cholesterol-fed rabbits by a water-soluble antioxidant-rich fraction of Salvia miltiorrhiza. Arterioscler. Thromb. Vasc. Biol. 18: 481-486.
8. Esterbauer, H., H. Puhl, M. Dieber-Rotheneder, G. Waeg and H. Rabl. 1991. Effect of antioxidants on oxidative modification of LDL. Ann. Med. 23: 573-581.
9. Esterbauer, H., G. Jurgens, O. Quehenberger, and E. Koller. 1987. Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J. Lipid Res. 28: 495-509.
10. Yagi, K. 1976. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem. Med. 15: 212-216.
11. 2 activity in endothelial cell-induced modification of low density lipoprotein. Proc. Natl. Acad. Sci. USA. 82: 3000-3004.
12. Fong, L. G., S. Parthasarathy, J. L. Witztum, and D. Steinberg. 1987. Nonenzymatic oxidative cleavage of peptide bonds in apoprotein B-100. J. Lipid Res. 28: 1466-1477.
13. Steinbrecher, U. P. 1987. Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J. Biol. Chem. 262: 3603-3608.
14. Henriksen, T., E. M. Mahoney, and D. Steinberg. 1983. Enhanced macrophage degradation of biologically modified low density lipoprotein. Arteriosclerosis. 3: 149-159.
15. Steinbrecher, U. P., M. Lougheed, W. C. Kwan, and M. Dirks. 1989. Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation. J. Biol. Chem. 264: 15216-15223.
16. Chait, A., and J. W. Heinecke. 1994. Lipoprotein modification: cellular mechanisms. Curr. Opin. Lipidol. 5: 365-370.
17. Steinbrecher, U. P., S. Parthasarathy, D. S. Leake, J. L. Witztum, and D. Steinberg. 1984. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA. 81: 3883-3887.
18. Lamb, D. J., and D. S. Leake. 1992. The effect of EDTA on the oxidation of low density lipoprotein. Atherosclerosis. 94: 35-42.
19. Sparrow, C. P., and J. Olszewski. 1992. Cellular oxidative modification of low density lipoprotein does not require lipoxygenases. Prof. Natl. Acad. Sci. USA. 89: 128-131.
20. Kugiyama, K., S. A. Kerns, J. D. Morrisett, R. Roberts, and P. D. Henry. 1990. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature. 344: 160-162.
21. Jessup, W., J. A. Simpson, and R. T. Dean. 1993. Does superoxide radical have a role in macrophage-mediated oxidative modification of LDL? Atherosclerosis. 99: 107-120.
22. Heinecke, J. W., L. Baker, H. Rosen, and A. Chait, 1984. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J. Clin. Invest. 74: 1890-1894.
23. Heinecke, J. W., H. Rosen, L. A. Suzuki, and A. Chait. 1987. The role of sulfur-containing amino acids in Superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J. Biol. Chem. 262: 10098-10103.
24. Sparrow, C. P. and J. Olszewski. 1993. Cellular oxidation of low density lipoprotein is caused by thiol production in media containing transition metal ions. J. Lipid Res. 34: 1219-1228.
25. Cathcart, M. K., D. W. Morel, and G. M. Chisolm. 1985. Monocytes and neutrophilis oxidize low density lipoprotein making it cytotoxic. J. Leukocyte Biol. 38: 341-350.
26. Cathcart, M. K., A. K. McNally, D. W. Morel, and G. M. Chisolm III. 1989. Superoxide anion participation in human monocyte-mediated oxidation of low density lipoprotein and conversion of low density lipoprotein to a cytotoxin. J. Immunol. 142: 1963-1969.
27. 2 in activated human monocytes. Regulation of superoxide anion production and LDL oxidation. J. Biol. Chem. 272:2404-2411.
28. Li, Q., and M. K. Cathcart. 1994. Protein kinase C is required for lipid oxidation of LDL by activated human monocytes. J. Biol. Chem. 269: 17508-17515.
29. Cathcart M. K., Q. Li, and C., M. Chisolm III. 1995. Lipoprotein receptor interactions are not required for monocytes oxidation of LDL. J. Lipid Res. 36: 1857-1865.
30. Johnston, R. B., D. O. Adams, P. J. Edelson, and H. Koren. 1981. Secretion of Superoxide anion. In Methods for Studying Mononuclear Phagocytes. Academic Press, New York. 489-498.
31. Buonassisi, V., and J. C. Venter. 1976. Hormone and neurotransmitter receptors in an established vascular endothelial cell line. Proc. Natl. Acad. Sci. USA. 73: 1612-1616.
32. Sparrow, C. P., S. Parthasarathy, and D. Steinberg. 1989. A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. J. Biol. Chem. 264: 2599-2604.
33. Havel, R. J., H. A. Eder, and J. H. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353.
34. Pittman, R. C., and C. A. Taylor, Jr. 1986. Methods for assessment of tissue sites of lipoprolein degradation. Methods Enzymol. 129: 613-628.
35. Brumby, P. E., and V. Massey. 1967. Determination of nonheme iron, total iron, and copper. Methods Enzymol. 10: 463-474.
36. 2 mimics cell-mediated oxidative modification. J. Lipid Res. 29: 745-753.
37. Bolann, B. J., and R. J. Ulvik. 1987. Release of iron from ferritin by xanthine oxidase. Biochem. J. 243: 55-59.
38. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
39. Marinetti, G. V. 1962. Chromatographic separation, identification, and analysis of phosphatides. J. Lipid. Res. 3: 1-30.
40. Jessup, W., D. Mohr, S. P. Gieseg, R. T. Dean, and R. Stocker. 1992. The participation of nitric oxide in cell free-and its restriction of macrophage-mediatcd oxidation of low-density iipoprotein. Biochim. Biophys. Acta. 1180: 73-82.
41. Darley-Usmar, V. M, N. Hogg, V. J. O'Leary, M. T. Wilson, and S. Moncada. 1992. The simultaneous generation of Superoxide and nitric oxide can initiate lipid peroxidation in human low density Iipoprotein. Free Radical Res. Commun. 17: 9-20.
42. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6: 3051-3064.
43. Gross, S. S., D. J. Stuehr, K. Aisaka, E. A. Jaffe, R. Levi and O. W. Griffith. 1990. Macrophage and endothelial cell nitric oxide synthesis: cell-type selective inhibition by N-aminoarginine, N-nitroarginine and N-methylarginine. Biochem. Biophys. Res. Commun. 170: 96-103.
44. O'Connor, K. J., and S. Moncada. 1991. Glucocorticoids inhibit the induction of nitric oxide synthase and the related cell damage in adenocarcinoma cells. Biochim. Biophys. Acta. 1097: 227-231.
45. Thomas, C. E., L. A. Morehouse, and S. D. Aust. 1985. Ferritin and superoxide-dependent lipid peroxidation. J. Biol. Chem. 260: 3275-3280.
46. Hiramatsu, K., H. Rosen, J. W. Heinecke, G. Wolfbauer, and A. Chait. 1987. Superoxide initiates oxidation of LDL by human monocytes. Arteriosclerosis. 7: 55-60.
47. Garner, B., D. van Reyk, R. T. Dean, and W. Jessup. 1997. Direct copper reduction by macrophages: its role in LDL oxidation. J. Biol. Chem. 272: 6927-6935.
48. Bonnefont-Rousselot, D., M. Gardes-Albert, S. Lepage, J. Delattre, and C. Ferradini. 1992. Effect of pH on LDL oxidation by Superoxide free radicals produced by gamma radiolysis. Radiat. Res. 132: 228-236.
49. Lynch, S. M., and B. Frei. 1993. Mechanisms of copper-and iron-dependent oxidative modification of human low density lipoprotein. J. Lipid. Res. 34: 1745-1753.
50. Steinbrecher, U. P. 1988. Role of Superoxide in endothelial cell modification of LDL. Biochim. Biophys. Acta. 959: 20-30.
51. Heinecke, J. W., L. Baker, H. Rosen, and A. Chait. 1986. Superoxide-mediated modification of LDL by arterial smooth muscle cells. J. Clin. Invest. 77: 757-761.
52. Kiechl, S., F. Aichner, F. Gerstenbrand, G. Egger, A. Mair, G. Rungger, F. Spogler, E. Jarosch, F. Oberhollenzer, and J. Willeit. 1994. Body iron stores and presence of carotid atherosclerosis. Arterioscler. Thromb. 14: 1625-1630.
53. Dabbagh, A. J., G. T. Shwaery, J. F. Keaney, and B. Frei. 1997. Effect of iron overload and iron deficiency on atherosclerosis in the hypercholesterolemic rabbit. Arterioscler. Thromb. Vasc. Biol. 17: 2638-2645.
54. Smith C., M. J. Mitchinson, O. I. Aruoma, and B. Halliwell. 1992. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem. J. 286: 901-905.
55. Wieland, E., S. Parthasarathy, and D. Steinberg. 1993. Peroxidase-dependem metal-independent oxidation of low density lipoprotein in vitro: a model for in vivo oxidation? Proc. Natl. Acad. Sci. USA. 90: 5929-5933.
56. Ezaki M., J. L. Witztum, and D. Steinberg. 1995. Lipoperoxides in LDL incubation with fibroblasts that overexpress 15-lipoxygenase. J. Lipid Res. 36: 1996-2004.
57. Savenkova M. L., D. M. Mueller, and J. W. Heinecke. 1994. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein. J. Biol. Chem. 269: 20394-20400.
58. Yla-Herttuala, S., M. E. Rosenfeld, S. Parthasarathy, C. K. Glass, E. Sigal, J. L. Witztum, and D. Steinberg. 1990. Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc. Natl. Acad. Sci. USA. 87: 6959-6963.
59. Daugherty, A. J. L. Dunn, D. L. Rateri, and J. W. Heinecke. 1994. Myeloperoxidase, a catalyst for Iipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94: 437-444.